Editorial Comment to Adrenalectomy in Japanese patients with subclinical Cushing syndrome: 1-mg dexamethasone suppression test to predict the surgical benefit

被引：0
|
作者：
Ishidoya, Shigeto [1 ]
机构：
[1] Sendai City Hosp, Dept Urol, Sendai, Miyagi, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2021年 / 28卷 / 03期
关键词：
D O I：
10.1111/iju.14455
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 279
页数：1
相关论文
共 37 条
  • [31] Assessment of 1 mg Dexamethasone Suppression Test in Patients with Obesity Before Bariatric Surgery
    Dilek Gogas Yavuz
    Tugce Apaydin
    Hatice Gizem Gunhan
    Meliha Melin Uygur
    Obesity Surgery, 2020, 30 : 4981 - 4985
  • [32] Ovine CRH Stimulation and 8 mg Dexamethasone Suppression Tests in 323 Patients With ACTH-Dependent Cushing's Syndrome
    Elenius, Henrik
    McGlotten, Raven
    Nieman, Lynnette K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (01): : E155 - E162
  • [33] The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome
    Tsagarakis, S
    Kokkoris, P
    Roboti, C
    Malagari, C
    Kaskarelis, J
    Vlassopoulou, V
    Alevizaki, C
    Thalassinos, N
    CLINICAL ENDOCRINOLOGY, 1998, 48 (05) : 627 - 633
  • [34] Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives
    Carton, Tiphaine
    Mathieu, Elise
    Wolff, Fleur
    Bouziotis, Jason
    Corvilain, Bernard
    Driessens, Natacha
    ENDOCRINOLOGY DIABETES & METABOLISM, 2021, 4 (03)
  • [35] Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Marta Araujo-Castro
    Felicia A. Hanzu
    Eider Pascual-Corrales
    Ana M. García Cano
    Marta Marchan
    Héctor F. Escobar-Morreale
    Pablo Valderrabano
    Gregori Casals
    Endocrine, 2023, 82 : 161 - 170
  • [36] Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro, Marta
    Hanzu, Felicia A.
    Pascual-Corrales, Eider
    Cano, Ana Garcia M.
    Marchan, Marta
    Escobar-Morreale, Hector F.
    Valderrabano, Pablo
    Casals, Gregori
    ENDOCRINE, 2023, 82 (01) : 161 - 170
  • [37] Editorial Comment from Dr Ishidoya to Increased expression of CYP17 and CYP11B1 in subclinical Cushing's syndrome due to adrenal adenomas
    Ishidoya, Shigeto
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (10) : 697 - 697
1234